Data from a massive real-world study of asthma patients has suggested that overuse of inhalers is widespread and leading to an elevated risk of severe exacerbations. The results from the SABINA ...

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a reminder to sufferers of the importance of using their preventer (anti-inflammatory) inhaler regularly as prescribed, and to ...

Patients are advised to continue using their daily preventer inhaler as prescribed, and to speak to a healthcare professional if they find themselves needing their blue inhaler more than twice a week.

People with asthma, chronic obstructive pulmonary disease (COPD), and certain other respiratory conditions typically receive Medicare coverage for inhalers. To receive coverage, a person must have ...

Today, sales of pharmaceutical inhalers exceed $36 billion globally each year, and the device has puffed its way into medical history, improving the lives of millions: More than 2,000 people ...

Experts from the University of Manchester have found that if a person with asthma takes their brown inhaler between 3pm and 4pm, they may see symptoms improve. The research, published in the ...

And anyone who needs to use their blue inhaler more than twice a week should be reviewed ... information for SABAs in 2024 to strengthen warnings on the risk of SABA overuse. Dr Alison Cave, chief ...

GSK withdrew the inhaler after a policy change exposed the company to higher Medicaid rebate costs WEDNESDAY, April 30, 2025 (HealthDay News) — More children stopped using steroid inhalers to ...